Fosun Pharma in Talks to Buy Lumenis Ltd. for $480 Million

Lumenis Ltd., which raised nearly $100 million through an initial public offering on NASDAQ last year, is in talks to be acquired by Chinese conglomerate Fosun for nearly $500 million, according to the Israeli financial newspaper Calcalist.

The paper reported that Fosun officials had made initial contact with executives from Yokneam, Israel-based Lumenis, who indicated that they would accept an offer of $480 million for the company, a 26% premium over its current market value.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC